|
C4ORF43 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.803800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.019400E-01 |
| Normal-vs-Stage2 |
1.986590E-01 |
| Normal-vs-Stage3 |
1.460770E-01 |
| Normal-vs-Stage4 |
1.831710E-02 |
| Stage1-vs-Stage2 |
3.189800E-01 |
| Stage1-vs-Stage3 |
3.514000E-01 |
| Stage1-vs-Stage4 |
2.121500E-02 |
| Stage2-vs-Stage3 |
8.691200E-01 |
| Stage2-vs-Stage4 |
2.270400E-01 |
| Stage3-vs-Stage4 |
1.186000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.895800E-02 |
| Normal-vs-AfricanAmerican |
3.618600E-01 |
| Normal-vs-Asian |
5.624600E-01 |
| Caucasian-vs-AfricanAmerican |
4.719800E-01 |
| Caucasian-vs-Asian |
9.055600E-01 |
| AfricanAmerican-vs-Asian |
7.131000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.164990E-01 |
| Normal-vs-Female |
2.826200E-02 |
| Male-vs-Female |
2.461200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.397400E-01 |
| Normal-vs-Extreme_Weight |
1.697750E-01 |
| Normal-vs-Obese |
5.242000E-02 |
| Normal-vs-Extreme_Obese |
7.808800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.659200E-01 |
| Normal_Weight-vs-Obese |
3.698800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.393400E-01 |
| Extreme_Weight-vs-Obese |
4.999800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.525800E-01 |
| Obese-vs-Extreme_Obese |
4.338400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.362100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.995800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.155400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.081200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.612400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.665700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.115410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.502420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.599200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.842200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.860200E-02 |
| Normal-VS-Type2 PRCC |
8.963600E-01 |
| Normal-VS-KIRP CIMP |
2.702400E-02 |
| Normal-VS-Unclassified PRCC |
1.576830E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.798180E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.274100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.094000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.170900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.080630E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.736100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.858400E-01 |
| Normal-vs-N1 |
4.959300E-03 |
| Normal-vs-N2 |
3.604600E-01 |
| N0-vs-N1 |
3.219800E-03 |
| N0-vs-N2 |
4.167800E-01 |
| N1-vs-N2 |
4.039200E-01 |
|
|
